SCHEMBL8045561

SCHEMBL8045561

c1coc(CN2CCCC2)c1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.55
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
TRPV6 Q9H1D0 1/20 0.51
ALDH1A1 P00352 4/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
HTT P42858 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
KDM4E B2RXH2 2/20 0.49
LTA4H P09960 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
LMNA P02545 1/20 0.48
TDP1 Q9NUW8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9551657 0.98 SIGMAR1 (0.54) SIGMAR1CYP2D6CYP2C9CYP2C19TRPV6
SCHEMBL31670698 0.96 SIGMAR1 (0.55) SIGMAR1CYP2D6CYP2C9CYP2C19TRPV6
SCHEMBL17157069 0.84 SMN1; SMN2 (0.55) SIGMAR1CYP2D6CYP2C9CYP2C19TRPV6
SCHEMBL14662295 0.84 CYP2D6 (0.51) SIGMAR1CYP2D6CYP2C9CYP2C19TRPV6
SCHEMBL7553199 0.83 ALDH1A1 (0.56) SIGMAR1CYP2D6CYP2C9CYP2C19TRPV6
SCHEMBL3569497 0.82 CYP2D6 (0.50) SIGMAR1CYP2D6CYP2C9CYP2C19TRPV6
SCHEMBL12536025 0.82 CYP2D6 (0.54) SIGMAR1CYP2D6CYP2C9CYP2C19TRPV6
SCHEMBL4906722 0.82 SIGMAR1 (0.52) SIGMAR1CYP2D6CYP2C9CYP2C19TRPV6
SCHEMBL3108724 0.82 SIGMAR1 (0.52) SIGMAR1CYP2D6CYP2C9CYP2C19TRPV6
Hydrochloric Acid SCHEMBL7228224 0.81 SIGMAR1 (0.50) SIGMAR1CYP2D6CYP2C9CYP2C19TRPV6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6160003-A 1,3,6-trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasia CELL PATHWAYS, INC. (US) 2000-12-12 US claimed